Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

GoodRx vs LifeMD

GoodRx
Graded #116

Higher grade

vs+11.799999999999997
LifeMD
Graded #390

Lower grade

The verdict

GoodRx takes it — 69.6/100 to 57.8/100.

GoodRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGoodRx +54
80
26
Dose & formulationGoodRx +6
70
64
Clinical oversightLifeMD +13
69
82
Labs & monitoringLifeMD +2
51
53
FulfillmentEven
81
81
Contract termsEven
55
55
GoodRx · left barLifeMD · right bar

The numbers

MetricGoodRxLifeMD
WeighScore69.6/10057.8/100
GradeCC
Scorecard rank#116#390
SemaglutideNot disclosedNot disclosed
Tirzepatide$299/mo (brand Zepbound)Not disclosed
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyYes
GoodRx

Graded #116 · C

Strengths

  • $149/month self-pay for brand-name Foundayo (orforglipron) — matches the lowest cash price at launch, far below typical retail
  • $299/month self-pay for Zepbound KwikPen — well under Lilly's typical cash list price
  • Honored at 70,000+ US pharmacies — the largest retail redemption network of any GLP-1 channel we cover
  • No membership fee — bring your own prescription and present the discount card at the pharmacy counter
  • Brand-name FDA-approved medication, not compounded

Where it loses points

  • Requires a valid prescription — GoodRx is a discount card, not a prescriber; you still need a clinician to write the script
  • Self-pay only — does not apply toward insurance benefits or deductibles
  • Headline price applies to the lowest Foundayo dose; higher doses may cost more
  • No compounded GLP-1 options — not the channel for compounded semaglutide or tirzepatide
  • Pricing can change as Lilly's manufacturer coupon program evolves
LifeMD

Graded #390 · C

Strengths

  • Telehealth convenience
  • Physician-supervised program

Where it loses points

  • Brand-name GLP-1 only — no lower-cost compounded option
  • Monthly program & provider fee ($149/mo, $75 first month) is separate from medication cost

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard